Lunch Innovation Theater (Non-Accredited): UZEDY: An Innovative Delivery Platform Allows for Rapid Absorption and Sustained Release of Risperidone

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Gustavo Alva, MD DFAPA

This presentation is provided by Teva Pharmaceuticals USA, Inc.